Lozada, Athara Hadarah Q.

HRN: 19-96-47  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2024
CEFTRIAXONE 1G (VIAL)
09/19/2024
09/26/2024
IV
730mg
Q12H
Typhoid Fever
Waiting Final Action 
09/21/2024
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
09/21/2024
09/25/2024
ORAL
4ml
OD
Typhoid Fever
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: